ABCL Stock Summary and Trading Ideas (Abcellera Biologics - Common Shares | NASDAQ:ABCL)

AbCellera Biologics Inc is a clinical-stage biotechnology company focused on discovering and developing first-in-class antibody medicines for indications with high unmet medical need. It has built a platform for advancing antibody drug programs that the company believes provides it with a competitive advantage in addressing challenging, high-value targets such as complex transmembrane proteins and novel modalities, including multispecifics and antibody-drug conjugates. Organisation's pipeline includes two drug candidates in clinical development, two development candidates in Investigational New Drug (IND/Clinical Trial Application (CTA)-enabling activities, and more than 20 active discovery programs across multiple modalities and indications.

Abcellera Biologics - Common Shares trades on the NASDAQ stock market under the symbol ABCL.

As of July 14, 2026, ABCL stock price climbed to $6.74 with 4,001,534 million shares trading.

ABCL has a beta of 2.56, meaning it tends to be more sensitive to market movements. ABCL has a correlation of 0.12 to the broad based SPY ETF.

ABCL has a market cap of $2.06 billion. This is considered a Mid Cap stock.

Last quarter Abcellera Biologics - Common Shares reported $8 million in Revenue and -$.14 earnings per share. This beat revenue expectation by $3 million and exceeded earnings estimates by $.06.

In the last 3 years, ABCL traded as high as $8.44 and as low as $1.89.

The top ETF exchange traded funds that ABCL belongs to (by Net Assets): IBB, CPAI, SPDW, IDNA, GWX.

ABCL has outperformed the market in the last year with a return of +68.1%, while the SPY ETF gained +21.8%. In the last 3 month period, ABCL beat the market returning +84.2%, while SPY returned +9.9%. However, in the most recent 2 weeks ABCL has underperformed the stock market by returning -17.0%, while SPY returned +1.5%.

ABCL support price is $6.13 and resistance is $6.91 (based on 1 day standard deviation move). This means that using the most recent 20 day stock volatility and applying a one standard deviation move around the stock's closing price, stastically there is a 67% probability that ABCL shares will trade within this expected range on the day.